{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:21:00Z","timestamp":1788344460975,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd010984","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000}}],"reference-count":282,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010984.pub2","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T20:17:00Z","timestamp":1445977020000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation"],"prefix":"10.1002","volume":"2015","author":[{"given":"Lise J","family":"Estcourt","sequence":"first","affiliation":[{"name":"NHS Blood and Transplant; Haematology\/Transfusion Medicine; Level 2, John Radcliffe Hospital Headington Oxford UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Stanworth","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals and the University of Oxford; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; Oxford UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Doree","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Systematic Review Initiative; John Radcliffe Hospital Oxford UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialena","family":"Trivella","sequence":"additional","affiliation":[{"name":"University of Oxford; Centre for Statistics in Medicine; Botnar Research Centre Windmill Road Oxford UK OX3 7LD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Hopewell","sequence":"additional","affiliation":[{"name":"University of Oxford; Centre for Statistics in Medicine; Botnar Research Centre Windmill Road Oxford UK OX3 7LD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Blanco","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Systematic Review Initiative; John Radcliffe Hospital Oxford UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"Murphy","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals and the University of Oxford; NHS Blood and Transplant; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; John Radcliffe Hospital Headington Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"key":"10.1002\/14651858.CD010984.pub2-BIB0001|cit1","doi-asserted-by":"crossref","unstructured":"Akay OM Sahin DG Andic N Gunduz E Karagulle M Colak E The utility of thromboelastometry in prophylactic platelet transfusion for hematological malignancies Transfusion and Apheresis Science 2015 [Epub ahead of print] 10.1016\/j.transci.2015.03.008","DOI":"10.1016\/j.transci.2015.03.008"},{"issue":"21","key":"10.1002\/14651858.CD010984.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"Abstract","DOI":"10.1182\/blood.V122.21.4826.4826","article-title":"Thromboelastographic follow-up of prophylactic thrombocyte transfusion","volume":"122","author":"Sahin","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD010984.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood-2008-09-178236","article-title":"A randomized controlled trial comparing standard and low dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia","volume":"113","author":"Heddle","year":"2009","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1537-2995.2011.03181.x","article-title":"Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges","volume":"51","author":"Heddle","year":"2011","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0005|cit5","unstructured":"NCT00420914 Strategies for Transfusion of Platelets (SToP) http:\/\/clinicaltrials.gov\/show\/NCT00420914"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1537-2995.1973.tb05490.x","article-title":"Prophylactic platelet transfusion in children with acute leukemia: A dose response study","volume":"13","author":"Roy","year":"1973","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0007|cit7","first-page":"(Abstract 2789)","article-title":"Increasing dose improves the platelet transfusions: results of a prospective multicentre randomised study","volume":"100","author":"Sensebe","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood-2004-05-1841","article-title":"The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study","volume":"105","author":"Sensebe","year":"2004","journal-title":"Blood"},{"issue":"Supplement","key":"10.1002\/14651858.CD010984.pub2-BIB0009|cit9","first-page":"188A","article-title":"Cost tradeoffs of low-, medium-, and high-dose platelet transfusions","volume":"53","author":"Assman","year":"2013","journal-title":"Transfusion"},{"issue":"S3","key":"10.1002\/14651858.CD010984.pub2-BIB0010|cit10","first-page":"19A","article-title":"Increased incidence of Grade 2 and higher bleeding in pediatric PLADO trial patients","volume":"49","author":"Josephson","year":"2009","journal-title":"Transfusion"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/trf.12791","article-title":"Transfusion-related adverse events in the platelet dose study","volume":"55","author":"Kaufman","year":"2015","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0012|cit12","unstructured":"NCT00128713 Optimal platelet dose strategy for management of thrombocytopenia http:\/\/clinicaltrials.gov\/show\/NCT00128713"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0015|cit13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jca.20090","article-title":"Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients","volume":"21","author":"Slichter","year":"2006","journal-title":"Journal of Clinical Apheresis"},{"issue":"11","key":"10.1002\/14651858.CD010984.pub2-BIB0013|cit14","doi-asserted-by":"crossref","first-page":"Abstract 285","DOI":"10.1182\/blood.V112.11.285.285","article-title":"Effects of prophylactic platelet (Plt) dose on transfusion (Tx) outcomes (PLADO trial).","volume":"112","author":"Slichter","year":"2008","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0014|cit15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of haemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"Abstract 21","DOI":"10.1182\/blood.V114.22.21.21","article-title":"Characteristics of transfused platelets do not affect bleeding outcomes in hypoproliferative thrombocytopenia","volume":"114","author":"Triulzi","year":"2009","journal-title":"Blood"},{"issue":"Supplement","key":"10.1002\/14651858.CD010984.pub2-BIB0017|cit17","first-page":"3A","article-title":"The effect of platelet characteristics on the platelet increment and HLA alloimmunization in hypoproliferative thrombocytopenia","volume":"50","author":"Triulzi","year":"2010","journal-title":"Transfusion"},{"issue":"23","key":"10.1002\/14651858.CD010984.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1182\/blood-2011-11-393165","article-title":"The impact of platelet transfusion characteristics on post-transfusion platelet increments and clinical bleeding in patients with hypo-proliferative thrombocytopenia","volume":"119","author":"Triulzi","year":"2012","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010984.pub2-BIB0019|cit19","first-page":"Various","article-title":"A dose response study of platelet transfusion: comparison between triple dose apheresis platelet transfusion and three split standard transfusions","volume":"87","author":"Steffens","year":"2002","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010984.pub2-BIB0020|cit20","first-page":"8","article-title":"A randomised phase II trial of low dose and standard dose platelet transfusions during induction therapy for acute leukemia or autologous stem cell transplantation","volume":"83","author":"Tinmouth","year":"2002","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.0041-1132.2004.04118.x","article-title":"Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor transplant and patients with acute leukaemia: a randomized controlled trial with a sequential Bayesian design","volume":"44","author":"Tinmouth","year":"2004","journal-title":"Transfusion Medicine"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00000441-198603000-00001","article-title":"Bleeding due to thrombocytopenia in acute leukaemias and reevaluation of the prophylactic platelet transfusion policy","volume":"291","author":"Aderka","year":"1986","journal-title":"American Journal of the Medical Sciences"},{"issue":"9S","key":"10.1002\/14651858.CD010984.pub2-BIB0023|cit23","first-page":"117A","article-title":"Clinical study in pediatric hemato-oncology patients: efficacy of pathogen inactivated platelets versus apheresis platelets","volume":"46","author":"Agliastro","year":"2006","journal-title":"Transfusion"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1423-0410.2007.00917.x","article-title":"Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy","volume":"93","author":"Akk\u00f6k","year":"2007","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-3148.1997.d01-73.x","article-title":"A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions","volume":"7","author":"Anderson","year":"1997","journal-title":"Transfusion Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tracli.2009.04.001","article-title":"Platelet transfusion: products, indications, dose, threshold and efficacy","volume":"16","author":"Andreu","year":"2009","journal-title":"Transfusion Clinique Et Biologique"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3476(05)81705-6","article-title":"A randomized controlled trial of platelet transfusions in thrombocytopenic premature infants","volume":"123","author":"Andrew","year":"1993","journal-title":"Journal of Pediatrics"},{"issue":"supplement","key":"10.1002\/14651858.CD010984.pub2-BIB0028|cit28","first-page":"1A","article-title":"A randomized crossover trial comparing in-vivo platelet recovery and survival of leukoreduced apheresis and whole blood derived platelets","volume":"44","author":"Arnold","year":"2004","journal-title":"Transfusion"},{"issue":"8","key":"10.1002\/14651858.CD010984.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1537-2995.2006.00892.x","article-title":"Utilization of platelet transfusions in the intensive care unit: Indications, transfusion triggers, and platelet count responses","volume":"46","author":"Arnold","year":"2006","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010984.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.critrevonc.2003.04.001","article-title":"Thrombocytopenia and hemorrhagic risk in cancer patients","volume":"48","author":"Avvisati","year":"2003","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0031|cit31","first-page":"437","article-title":"A multi-centre clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor","volume":"26","author":"Bai","year":"2004","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao Acta Academiae Medicinae Sinicae"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1040-8428(01)00182-2","article-title":"What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?","volume":"42","author":"Benjamin","year":"2002","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0033|cit33","unstructured":"Bentley M Taylor K Kelly C Taylor D Leach B Rodwell R Thrombopoietin derived autologous cryopreserved platelet support for peripheral blood progenitor cell transplantation Haematology Society of Australia and New Zealand Annual Scientific Meeting Perth"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0034|cit34","first-page":"198","article-title":"New strategies for the optimal use of platelet transfusions","volume":"2008","author":"Blajchman","year":"2008","journal-title":"Hematology\/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program"},{"issue":"9S","key":"10.1002\/14651858.CD010984.pub2-BIB0035|cit35","first-page":"5S (Abstract","article-title":"Platelet transfusion and clinical outcome in acute leukemia in adults","volume":"42","author":"Blumberg","year":"2002","journal-title":"Transfusion"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"on-line only","DOI":"10.1186\/1471-2326-4-6","article-title":"A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]","volume":"4","author":"Blumberg","year":"2004","journal-title":"BMC Blood Disorders"},{"issue":"10","key":"10.1002\/14651858.CD010984.pub2-BIB0037|cit37","first-page":"215A","article-title":"A prospective randomised study of platelet concentrates irradiated with ultraviolet (UV)-B light in patients with high grade haematological malignancy","volume":"80","author":"Blundell","year":"1992","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1537-2995.1996.36496226140.x","article-title":"A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy","volume":"36","author":"Blundell","year":"1996","journal-title":"Transfusion"},{"issue":"10","key":"10.1002\/14651858.CD010984.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/j.1537-2995.2010.02688.x","article-title":"An update on platelet transfusion in hemato-oncology supportive care","volume":"50","author":"Buhrkuhl","year":"2010","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2141.2002.03616.x","article-title":"The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy","volume":"118","author":"Callow","year":"2002","journal-title":"British Journal of Haematology"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1537-2995.2007.01090.x","article-title":"Evaluation of platelet transfusion triggers in a tertiary-care hospital","volume":"47","author":"Cameron","year":"2007","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2141.1990.tb04356.x","article-title":"Transfusion of ABO-mismatched platelets leads to early platelet refractoriness","volume":"75","author":"Carr","year":"1990","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2044.2004.03711.x","article-title":"The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery. A systematic review","volume":"59","author":"Casbard","year":"2004","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1537-2995.2005.04286.x","article-title":"Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy","volume":"45","author":"Chaoui","year":"2005","journal-title":"Transfusion"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0045|cit45","first-page":"249","article-title":"'Bleeding' and 'transfusion support' in acute myeloid leukemia patients: The challenges","volume":"28","author":"Chaurasia","year":"2012","journal-title":"Indian Journal of Hematology and Blood Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1537-2995.2006.01137.x","article-title":"Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials","volume":"47","author":"Cid","year":"2007","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1537-2995.2002.00070.x","article-title":"Platelet transfusions in children: results of a randomised prospective cross-over trial of plasma removal and a prospective audit of WBC reduction","volume":"42","author":"Couban","year":"2002","journal-title":"Transfusion"},{"issue":"12","key":"10.1002\/14651858.CD010984.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bmt.1704675","article-title":"Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma","volume":"34","author":"Decaudin","year":"2004","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1537-2995.2000.40040398.x","article-title":"Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study","volume":"40","author":"Wildt-Eggen","year":"2000","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1537-2995.2005.04157.x","article-title":"A prospective randomised trial of a prophylactic platelet transfusion trigger of 10 x 109 per L versus 30 x 109 per L in allogeneic hematopoietic progenitor cell transplant recipients","volume":"45","author":"Diedrich","year":"2005","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1423-0410.2009.01197.x","article-title":"A randomised study of buffy coat platelets in platelet additive solution 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic cell transplant recipients","volume":"97","author":"Diedrich","year":"2009","journal-title":"Vox Sanguinis"},{"issue":"Supp 1","key":"10.1002\/14651858.CD010984.pub2-BIB0052|cit52","first-page":"Abstract","article-title":"A randomized study in allogeneic haematopoietic stem cell transplant recipients comparing prophylactic transfusion of buffy coat platelets stored for 1-5 vs. 6-7 days","volume":"95","author":"Diedrich","year":"2008","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0053|cit53","first-page":"1241","article-title":"A randomized controlled trial comparing autologous radiolabeled in vivo platelet(plt) recoveries and survivals of 7-day-stored plt-rich plasma and buffy coat plts from the same subjects","volume":"6","author":"Dumont","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0054|cit54","first-page":"324","article-title":"Predicting hemorrhage using preoperative coagulation screening assays","volume":"3","author":"Dzik","year":"2004","journal-title":"Current Hematology Reports"},{"issue":"7","key":"10.1002\/14651858.CD010984.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1537-2995.2007.01248.x","article-title":"Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: The American Red Cross Experience (2004-2006)","volume":"47","author":"Eder","year":"2007","journal-title":"Transfusion"},{"issue":"12","key":"10.1002\/14651858.CD010984.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1002\/cncr.10603","article-title":"The bleeding risk index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors","volume":"94","author":"Elting","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/cncr.11195","article-title":"Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors","volume":"97","author":"Elting","year":"2003","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/gyno.1995.0006","article-title":"Conservative management of chemotherapy-induced thrombocytopenia in women with gynecological cancers","volume":"59","author":"Fanning","year":"1995","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0059|cit59","first-page":"233","article-title":"Homologous platelet concentrates: products available and utilisation rules in oncology and haematology","volume":"10","author":"Follea","year":"2004","journal-title":"Hematologie"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0060|cit60","unstructured":"Franklin IM Clinical efficacy of platelet transfusions Within previous version of this Cochrane review. Stanworth 2004"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/tmrv.2002.29403","article-title":"Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients?","volume":"16","author":"Friedmann","year":"2002","journal-title":"Transfusion Medicine Reviews"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD010984.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1097\/01.CCM.0000214288.88308.26","article-title":"Fresh frozen plasma and platelet transfusion for non-bleeding patients in the intensive care unit: Benefit or harm?","volume":"35","author":"Gajic","year":"2006","journal-title":"Critical Care Medicine"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/j.1537-2995.2009.02253.x","article-title":"Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit","volume":"49","author":"Gerday","year":"2009","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0064|cit64","first-page":"931","article-title":"Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution","volume":"18","author":"Gil-Fernandez","year":"1996","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood.V62.2.473.473","article-title":"Delayed alloimmunization using random single donor platelet transfusions: a prospective study in thrombocytopenic patients with acute leukemia","volume":"62","author":"Gmur","year":"1983","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0140-6736(91)92098-M","article-title":"Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia","volume":"338","author":"Gm\u00fcr","year":"1991","journal-title":"The Lancet"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood.V98.5.1346","article-title":"Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin","volume":"98","author":"Goodnough","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD010984.pub2-BIB0068|cit68","first-page":"1558","article-title":"Issues in the management of cancer-related thrombocytopenia","volume":"16","author":"Goodnough","year":"2002","journal-title":"Oncology"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.atc.2004.07.004","article-title":"Risks of blood transfusion","volume":"23","author":"Goodnough","year":"2005","journal-title":"Anesthesiology Clinics of North America"},{"issue":"S2","key":"10.1002\/14651858.CD010984.pub2-BIB0070|cit70","first-page":"20A","article-title":"Clinical evaluation of Mirasol PRT treated apheresis platelets in thrombocytopenic patients","volume":"48","author":"Goodrich","year":"2008","journal-title":"Transfusion"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1537-2995.2007.01089.x","article-title":"Platelet utilisation and the transfusion trigger: A prospective analysis","volume":"72","author":"Greeno","year":"2007","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0072|cit72","first-page":"271","article-title":"Preliminary report on a randomized study of prophylactic vs. therapeutic platelet transfusions","volume":"80","author":"Grossman","year":"1980","journal-title":"International Society Blood Transfusion Abstract Book"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.bmt.1705751","article-title":"Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML\/MDS patients receiving allogeneic hematopoietic stem cell transplantation","volume":"40","author":"Gurkan","year":"2007","journal-title":"Bone Marrow Transplantation"},{"issue":"Supplement","key":"10.1002\/14651858.CD010984.pub2-BIB0074|cit74","first-page":"Abstract 330","article-title":"Safety of stringent prophylactic platelet transfusion (PT) policy for lymphoma patients treated by high dose chemotherapy (HDC) and autologous stem cell support.","volume":"14","author":"Hardan","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0075|cit75","unstructured":"Harrup RA Kennedy JT Kiss J Daniels B Randomised blinded comparison of buffy coat plasma or T-sol supported platelet transfusions Haematology Society of Australia and New Zealand Annual Scientific Meeting Hobart; Tasmania October 1999"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0076|cit76","first-page":"349a","article-title":"A survival advantage in leukaemics receiving ABO identical platelets","volume":"78","author":"Heal","year":"1991","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0077|cit77","first-page":"348a","article-title":"The importance of ABO identical platelet transfusions","volume":"78","author":"Heal","year":"1991","journal-title":"Blood"},{"issue":"7 Supp 1","key":"10.1002\/14651858.CD010984.pub2-BIB0078|cit78","first-page":"215a","article-title":"A randomised trial of ABO identical versus ABO unmatched platelet transfusions","volume":"74","author":"Heal","year":"1989","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0609.1993.tb00150.x","article-title":"The role of ABO matching in platelet transfusion","volume":"50","author":"Heal","year":"1993","journal-title":"European Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0268-960X(03)00057-2","article-title":"Optimizing platelet transfusion therapy","volume":"18","author":"Heal","year":"2004","journal-title":"Blood Reviews"},{"issue":"Abstract","key":"10.1002\/14651858.CD010984.pub2-BIB0081|cit81","first-page":"192a","article-title":"Randomized evaluation of the optimal platelet count for prophylactic platelet transfusions in patients undergoing induction therapy for acute leukaemia. American Society of Hematology 35th Annual Meeting","volume":"82","author":"Heckman","year":"1993","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1200\/JCO.1997.15.3.1143","article-title":"Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukaemia: 10 x 109\/L versus 20 x 109\/L","volume":"15","author":"Heckman","year":"1997","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD010984.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199409083311001","article-title":"The role of the plasma from platelet concentrates in transfusion reactions","volume":"331","author":"Heddle","year":"1994","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1537-2995.1999.39399219278.x","article-title":"A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets","volume":"39","author":"Heddle","year":"1999","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1537-2995.2002.00094.x","article-title":"A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets","volume":"42","author":"Heddle","year":"2002","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1046\/j.1537-2995.2003.00418.x","article-title":"Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies","volume":"43","author":"Heddle","year":"2003","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1751-2824.2007.00093.x","article-title":"Controversy concerning platelet dose","volume":"2","author":"Heddle","year":"2007","journal-title":"ISBT Science Series, Vol 2, No 1: State of the Art Presentations"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1537-2995.1974.tb04558.x","article-title":"The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study","volume":"14","author":"Higby","year":"1974","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0089|cit89","unstructured":"Hillbom ME Platelet Transfusion in Acute Intracerebral Haemorrhage Clinical Trials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00699621"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0090|cit90","unstructured":"ISRCTN49080246 Platelet Process Improvement Project http:\/\/www.controlled-trials.com\/ISRCTN49080246"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00024669-200605060-00004","article-title":"Chemotherapy-associated thrombocytopenia current and emerging management strategies","volume":"5","author":"Jelic","year":"2006","journal-title":"American Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1537-2995.2007.01160.x","article-title":"Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice","volume":"47","author":"Johansson","year":"2007","journal-title":"Transfusion"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1537-2995.2008.01914.x","article-title":"Transfusion efficacy of ABO major-mismatched platelets (PLTS) in children is inferior to that of ABO-identical platelets","volume":"91","author":"Julmy","year":"2009","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0094|cit94","first-page":"600","article-title":"Alloimmunization following apheresis platelets vs. pooled platelet concentrates. A prospective randomized study","volume":"21","author":"Kakaiya","year":"1981","journal-title":"Transfusion"},{"issue":"s3","key":"10.1002\/14651858.CD010984.pub2-BIB0095|cit95","first-page":"2A","article-title":"Clinical effectiveness and safety of pooled, random donor platelet concentrates, leucoreduced and stored up to seven days in either plasma or additive solution with and without pathogen reduction in hemato-oncological patients","volume":"49","author":"Kerkhoffs","year":"2009","journal-title":"Transfusion"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.2010.08227.x","article-title":"Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction","volume":"150","author":"Kerkhoffs","year":"2010","journal-title":"British Journal of Haematology"},{"issue":"12","key":"10.1002\/14651858.CD010984.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1046\/j.1537-2995.2000.40121457.x","article-title":"Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double-blind trial","volume":"40","author":"Ackerman","year":"2000","journal-title":"Transfusion"},{"issue":"10s","key":"10.1002\/14651858.CD010984.pub2-BIB0098|cit98","first-page":"46S","article-title":"The effect of platelet dose on the outcome of prophylactic platelet transfusion","volume":"35","author":"Hermann","year":"1995","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0099|cit99","first-page":"536","article-title":"The effect of platelet dose on the interval between platelet transfusions in patients undergoing bone marrow or peripheral blood stem cell transplantation","volume":"14","author":"Klumpp","year":"1995","journal-title":"Journal of Clinical Oncology (Proceedings of ASCO)"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1537-2995.1999.39070674.x","article-title":"Clinical consequences of alterations in platelet dose: a prospective, randomized, double-blind trial","volume":"39","author":"Klumpp","year":"1999","journal-title":"Transfusion"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002770050206","article-title":"In-vivo evaluation of random donor platelet concentrates from pooled buffy coats","volume":"73","author":"Kluter","year":"1996","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0102|cit102","unstructured":"Lapierre V Benhamou E Tramalloni D Brault P Valteau-Couanet D Ducourtieux M A randomised trial of platelet transfusion policies after blood stem cell transplantation in young children: reduction of number of single platelet concentrate donors per child European Group for Blood and Bone Marrow Transplantation Annual Congress Istanbul, Turkey P756"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10428190109057955","article-title":"Lowering the prophylactic platelet transfusion threshold: a prospective analysis","volume":"41","author":"Lawrence","year":"2001","journal-title":"Leukemia & Lymphoma"},{"issue":"Suppl","key":"10.1002\/14651858.CD010984.pub2-BIB0104|cit104","first-page":"20S","article-title":"Use of warmed single donor platelets in autologous bone marrow transplant patients","volume":"31","author":"Leach","year":"1991","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1537-2995.1989.29589284135.x","article-title":"ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial","volume":"29","author":"Lee","year":"1989","journal-title":"Transfusion"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010984.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03165104","article-title":"Management of bleeding disorders by prohemostatic therapy","volume":"76","author":"Levi","year":"2002","journal-title":"International Journal of Hematology"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pharmthera.2009.03.019","article-title":"Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence","volume":"123","author":"Lordkipanidze","year":"2009","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/tmrv.2003.50003","article-title":"The clinical implications of platelet transfusions associated with ABO or Rh[D) incompatibility","volume":"17","author":"Lozano","year":"2003","journal-title":"Transfusion Medicine Reviews"},{"issue":"Supp 2","key":"10.1002\/14651858.CD010984.pub2-BIB0109|cit109","first-page":"25A","article-title":"Frequency of prophylactic transfusion failure: a novel outcome to evaluate platelet components stored more than 5 days","volume":"50","author":"Lozano","year":"2010","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2141.2011.08635.x","article-title":"A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotsalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion","volume":"153","author":"Lozano","year":"2011","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0111|cit111","first-page":"295","article-title":"Effect of reducing prophylactic platelet transfusion dose on bleeding in thrombocytopenia patients","volume":"34","author":"Lu","year":"2011","journal-title":"International Journal of Blood Transfusion and Hematology"},{"issue":"S1","key":"10.1002\/14651858.CD010984.pub2-BIB0112|cit112","first-page":"310 (P-577)","article-title":"Effect of reducing prophylactic platelet transfusion dose on bleeding in thrombocytopenic patients","volume":"101","author":"Lu","year":"2011","journal-title":"Vox Sanguinis"},{"issue":"11","key":"10.1002\/14651858.CD010984.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"708a","DOI":"10.1182\/blood.V104.11.2587.2587","article-title":"A meta-analysis to determine the risk of heparin induced thrombocytopenia (HIT) and isolated thrombocytopenia in prophylaxis studies comparing unfractionated heparin (UFH) and low molecular weight heparin (LMWH)","volume":"104","author":"Martel","year":"2004","journal-title":"Blood"},{"issue":"9S","key":"10.1002\/14651858.CD010984.pub2-BIB0114|cit114","first-page":"9A","article-title":"Fresh (1-2 day-old) vs. aged (4-5 day-old) INTERCEPT platelets and conventional platelets provide comparable count increments. However fresh platelets result in superior hemostasis: results of the SPRINT trial","volume":"43","author":"Benjamin","year":"2003","journal-title":"Transfusion"},{"issue":"9S","key":"10.1002\/14651858.CD010984.pub2-BIB0115|cit115","first-page":"17S","article-title":"A platelet transfusion threshold of 20 x 109\/L compared to 10 x 109\/L is associated with increased pre-transfusion bleeding and increased platelet transfusions: results of the SPRINT study","volume":"42","author":"Goodnough","year":"2002","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010984.pub2-BIB0116|cit116","first-page":"110a","article-title":"Apheresis platelets treated with the INTERCEPT Blood System for pathogen inactivation provide platelet count increments and hemostasis comparable to conventional platelets","volume":"83","author":"Kluter","year":"2002","journal-title":"Vox Sanguinis"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2003-12-4443","article-title":"Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial","volume":"104","author":"McCullough","year":"2004","journal-title":"Blood"},{"issue":"109","key":"10.1002\/14651858.CD010984.pub2-BIB0118|cit118","first-page":"Abstract","article-title":"INTERCEPT platelets are hemostatically as effective as conventional platelet in the prophylaxis and treatment of bleeding: results of the SPRINT trial","volume":"83","author":"Murphy","year":"2002","journal-title":"Vox Sanguinis"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1537-2995.2005.00671.x","article-title":"Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light","volume":"46","author":"Murphy","year":"2006","journal-title":"Transfusion"},{"issue":"Pt 2","key":"10.1002\/14651858.CD010984.pub2-BIB0120|cit120","first-page":"141b","article-title":"INTERCEPT platelets (plts) and conventional plts provide comparable hemostatic response in thrombocytopenic patients: the SPRINT trial","volume":"11","author":"Slichter","year":"2002","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010984.pub2-BIB0121|cit121","first-page":"Various","article-title":"Intercept platelets exhibit immunological refractoriness comparable to conventional platelets","volume":"89","author":"Strauss","year":"2004","journal-title":"Haematologica"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1254\/jphs.93.381","article-title":"Platelets and platelet therapy","volume":"93","author":"McNicol","year":"2003","journal-title":"Journal of Pharmacological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/1097-0142(19880815)62:4<795::AID-CNCR2820620426>3.0.CO;2-7","article-title":"A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients","volume":"62","author":"Messerschmidt","year":"1988","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/j.1537-2995.2010.02694.x","article-title":"A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology","volume":"50","author":"The Mirasol Clinical Evaluation Study Group","year":"2010","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajh.2830120406","article-title":"Indications for platelet transfusion in children with acute leukemia","volume":"12","author":"Murphy","year":"1982","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.1986.tb02965.x","article-title":"Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization","volume":"62","author":"Murphy","year":"1986","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0127|cit127","first-page":"998","article-title":"Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000\/mL","volume":"83","author":"Navarro","year":"1998","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0128|cit128","unstructured":"NCT00180986 Randomized trial of platelet transfusion policies after blood stem cells transplantation in young children: Reduction of number of single platelet concentrate donors per child http:\/\/clinicaltrials.gov\/show\/NCT00180986"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1537-2995.2007.01193.x","article-title":"Acute bleeding complications in patients after haematopoietic stem cell transplantation triggers of 10 x 109 and 20 x 109 per L","volume":"47","author":"Nevo","year":"2007","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood.V92.4.1448","article-title":"Platelet transfusion: a dose response study","volume":"92","author":"Norol","year":"1998","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1537-2995.1991.31791368333.x","article-title":"Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components: A randomized trial","volume":"31","author":"Oksanen","year":"1991","journal-title":"Transfusion"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1423-0410.1994.tb01273.x","article-title":"Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat","volume":"67","author":"Oksanen","year":"1994","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0133|cit133","unstructured":"NCT01615146 Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot http:\/\/clinicaltrials.gov\/show\/NCT01615146"},{"issue":"10","key":"10.1002\/14651858.CD010984.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/MPH.0b013e3181b794d0","article-title":"Evaluation of the effects of different transfusion trigger levels during the treatment of childhood acute lymphoblastic leukemia","volume":"31","author":"Paananen","year":"2009","journal-title":"Journal of Pediatric Haematology\/Oncology"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0135|cit135","first-page":"343","article-title":"Comparative clinical studies of platelet concentrates: Effects on clinical outcome and the use of healthcare resources","volume":"17","author":"Pamphilon","year":"1996","journal-title":"Transfusion Science"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0136|cit136","first-page":"231","article-title":"Pharmacological alternatives to blood transfusion: what is new about?","volume":"122","author":"Paramo","year":"2004","journal-title":"Medicina Clinica"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0137|cit137","first-page":"139","article-title":"Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?","volume":"2","author":"Poon","year":"2003","journal-title":"Current Hematology Reports"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tracli.2008.01.002","article-title":"National comparative audit of the use of platelet transfusions in the UK","volume":"14","author":"Qureshi","year":"2007","journal-title":"Transfusion Clinique Et Biologique"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0139|cit139","first-page":"11","article-title":"Dose of prophylactic platelet transfusions did not affect bleeding incidence or severity","volume":"152","author":"Rabinowitz","year":"2010","journal-title":"ACP Journal Club"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0140|cit140","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004226.pub2","article-title":"Antenatal interventions for fetomaternal alloimmune thrombocytopenia","author":"Rayment","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MCG.0b013e31823d33e3","article-title":"Platelet transfusion threshold in patients with upper gastrointestinal bleeding: a systematic review","volume":"46","author":"Razzaghi","year":"2012","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1537-2995.2004.03231.x","article-title":"Methods for the analysis of bleeding outcomes in randomised trials of platelet transfusion triggers","volume":"44","author":"Cook","year":"2004","journal-title":"Transfusion"},{"issue":"Supplement","key":"10.1002\/14651858.CD010984.pub2-BIB0143|cit143","first-page":"768","article-title":"The platelet transfusion trigger trial (PTTT): a multivariate analysis of risk factors for major bleeding in acute myeloid leukemia (AML)","volume":"78","author":"Finazzi","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"issue":"10","key":"10.1002\/14651858.CD010984.pub2-BIB0144|cit144","first-page":"443a","article-title":"Interim report from the platelet transfusion trigger trial (PTTT): a prospective controlled study on bleeding risk in acute myeloid leukaemia (AML) patients randomized to be transfused at 10 versus 20 x 109\/L platelets","volume":"88","author":"GIMMEMA Group","year":"1996","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1537-2995.2006.00822.x","article-title":"A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukaemia","volume":"46","author":"Heddle","year":"2006","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in adults with acute myeloid leukaemia","volume":"337","author":"Rebulla","year":"1997","journal-title":"The New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD010984.pub2-BIB0147|cit147","first-page":"1530","article-title":"The risk of bleeding in thrombocytopenic patients with acute myeloid leukaemia","volume":"91","author":"Webert","year":"2006","journal-title":"Haematologica"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00000658-198601000-00008","article-title":"Prophylactic platelet administration during massive transfusion. A prospective, randomized, double-blind clinical study","volume":"203","author":"Reed","year":"1986","journal-title":"Annals of Surgery"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00008480-200302000-00004","article-title":"Thrombocytopenia in the newborn","volume":"15","author":"Roberts","year":"2003","journal-title":"Current Opinion in Pediatrics"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1182\/blood.V93.9.3124","article-title":"A restrictive platelet transfusion policy allowing long term support of outpatients with severe aplastic anaemia","volume":"93","author":"Sagmeister","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0151|cit151","first-page":"1025","article-title":"Prevention of hemorrhage occurring in patients with leukemia","volume":"92","author":"Sakakura","year":"2003","journal-title":"Zassh (Nippon-Naika-Gakkai-Zasshi)"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF03018577","article-title":"Perioperative platelet transfusion: recommendations of the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSaPS) 2003","volume":"52","author":"Samama","year":"2005","journal-title":"Canadian Journal of Anaesthesia"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0153|cit153","first-page":"447","article-title":"Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency (AFSSAPS) 2003","volume":"72","author":"Samama","year":"2006","journal-title":"Minerva Anestesiologica"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V62.4.815.815","article-title":"A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia","volume":"62","author":"Schiffer","year":"1983","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0609.1992.tb00035.x","article-title":"A randomized trial comparing the use of fresh and stored platelets in the treatment of bone marrow transplant recipients","volume":"49","author":"Shanwell","year":"1992","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/j.1537-2995.2009.02273.x","article-title":"ABO-identical versus non-identical platelet transfusion: a systematic review","volume":"49","author":"Shehata","year":"2009","journal-title":"Transfusion"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.hoc.2007.06.001","article-title":"Acquired platelet dysfunction","volume":"21","author":"Shen","year":"2007","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"5 Supp","key":"10.1002\/14651858.CD010984.pub2-BIB0158|cit158","first-page":"285A","article-title":"A prospective randomized study of platelet support in leukemic patients","volume":"72","author":"Singer","year":"1988","journal-title":"Transfusion"},{"issue":"8223","key":"10.1002\/14651858.CD010984.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(81)92626-X","article-title":"Delayed alloimmunisation by random single donor platelet transfusions. A randomised study to compare single donor and multiple donor platelet transfusions in cancer patients with severe thrombocytopenia","volume":"1","author":"Sintnicolaas","year":"1981","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0160|cit160","first-page":"684","article-title":"Comparison of prophylactic and therapeutic single-donor platelet transfusions in patients with acute leukaemia","volume":"50","author":"Sintnicolaas","year":"1982","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/blood.V85.3.824.bloodjournal853824","article-title":"Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: A randomized prospective study","volume":"85","author":"Sintnicolaas","year":"1995","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0162|cit162","first-page":"Abstract","article-title":"Prospective randomized transfusion trial to directly compare fresh and stored apheresis platelets (AP) and pooled random donor platelet concentrates (PC) in thrombocytopenic patients","volume":"92","author":"Slichter","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tmrv.2004.03.003","article-title":"Relationship between platelet count and bleeding risk in thrombocytopenic patients","volume":"18","author":"Slichter","year":"2004","journal-title":"Transfusion Medicine Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1537-2995.2006.00791.x","article-title":"Platelets photochemically treated with amotsalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia","volume":"46","author":"Slichter","year":"2006","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1182\/asheducation-2007.1.172","article-title":"Evidence-based platelet transfusion guidelines","volume":"2007","author":"Slichter","year":"2007","journal-title":"Hematology\/the Education Program of the American Society of Hematology"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0166|cit166","first-page":"227","article-title":"Effects of platelet (Plt) dose on transfusion outcomes","volume":"22","author":"Slichter","year":"2012","journal-title":"Transfusion Medicine"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(78)90505-6","article-title":"Platelet prophylaxis in acute non-lymphoblastic leukemia","volume":"1 (8058)","author":"Solomon","year":"1978","journal-title":"The Lancet"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00005237-200307000-00003","article-title":"Alloimmune thrombocytopenia in the fetus: current management theories","volume":"17","author":"Sosa","year":"2003","journal-title":"The Journal of Perinatal & Neonatal Nursing"},{"issue":"8","key":"10.1002\/14651858.CD010984.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1537-2995.2004.03322.x","article-title":"Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes","volume":"44","author":"Spiess","year":"2004","journal-title":"Transfusion"},{"issue":"10","key":"10.1002\/14651858.CD010984.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/trf.12697","article-title":"Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial","volume":"54","author":"Campbell","year":"2014","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0171|cit171","unstructured":"ISRCTN08758735 A randomised controlled trial of prophylactic versus no-prophylactic platelet transfusions in patients with haematological malignancies http:\/\/www.controlled-trials.com\/ISRCTN08758735"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0172|cit172","first-page":"46","article-title":"Objective assessment of bleeding in patients with haematological malignancies in an international study of platelet transfusions - how was consistency achieved. 31st Annual Scientific Meeting of the British Blood Transfusion Society, Birmingham","volume":"23","author":"Powter","year":"2013","journal-title":"Transfusion Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.tmrv.2009.11.002","article-title":"Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions","volume":"24","author":"Stanworth","year":"2010","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"Supplement 1, A","DOI":"10.1182\/blood.V120.21.1.1","article-title":"The effect of a no-prophylactic versus prophylactic platelet transfusion strategy on bleeding in patients with hematological malignancies and severe thrombocytopenia (TOPPS trial). A randomized controlled, non-inferiority trial","volume":"120","author":"Stanworth","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD010984.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/trf.12646","article-title":"Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial","volume":"54","author":"Stanworth","year":"2014","journal-title":"Transfusion"},{"issue":"19","key":"10.1002\/14651858.CD010984.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A no-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3324\/haematol.2014.118075","article-title":"Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis","volume":"100","author":"Stanworth","year":"2015","journal-title":"Haematologica"},{"issue":"21","key":"10.1002\/14651858.CD010984.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"Abstract","DOI":"10.1182\/blood.V124.21.1551.1551","article-title":"Risk factors for bleeding: A modelling analysis of the TOPPS randomized controlled trial of prophylactic platelet transfusion","volume":"124","author":"Wood","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD010984.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/j.0041-1132.2004.04378.x","article-title":"Low-dose prophylactic platelet transfusions: Time for further study, but too early for routine clinical practice","volume":"44","author":"Strauss","year":"2004","journal-title":"Transfusion"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0180|cit180","first-page":"499","article-title":"Pretransfusion trigger platelet counts and dose for prophylactic platelet transfusions","volume":"12","author":"Strauss","year":"2005","journal-title":"Current Opinion in Hematology"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0609.1996.tb01382.x","article-title":"Transfusion of platelet concentrates - clinical evaluation of two preparations","volume":"57","author":"Strindberg","year":"1996","journal-title":"European Journal of Haematology"},{"issue":"7","key":"10.1002\/14651858.CD010984.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1537-2995.2000.40070794.x","article-title":"A comparison of prestorage WBC-reduced whole blood derived platelets in autologous progenitor cell transplant","volume":"40","author":"Sweeney","year":"2000","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0887-7963(03)00018-X","article-title":"Prophylactic platelet transfusions: which dose is the best dose? A review of the literature","volume":"17","author":"Tinmouth","year":"2003","journal-title":"Transfusion Medicine Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.thromres.2009.06.009","article-title":"Management of bleeding and of invasive procedures in patients with platelet disorders and\/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)","volume":"125","author":"Tosetto","year":"2009","journal-title":"Thrombosis Research"},{"issue":"11","key":"10.1002\/14651858.CD010984.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1537-2995.2003.00529.x","article-title":"Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial","volume":"43","author":"Enright","year":"2003","journal-title":"Transfusion"},{"issue":"10","key":"10.1002\/14651858.CD010984.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions","volume":"337","author":"The Trial to Reduce Alloimmunization to Platelets Study Group","year":"1997","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(02)09090-6","article-title":"Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study","volume":"359","author":"Vadhan-Raj","year":"2002","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood.V77.1.201.201","article-title":"Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: A prospective, randomized trial","volume":"77","author":"Marwijk Kooy","year":"1991","journal-title":"Blood"},{"issue":"4 Supp 11","key":"10.1002\/14651858.CD010984.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0037-1963(01)90123-4","article-title":"Design of clinical trials to evaluate the efficacy of platelet transfusion: the euroSPRITE trial for components treated with Helinx technology","volume":"38","author":"Cazenave","year":"2001","journal-title":"Seminars in Hematology"},{"issue":"Supp 1","key":"10.1002\/14651858.CD010984.pub2-BIB0191|cit191","first-page":"Various","article-title":"INTERCEPT buffy coat platelets (IPC) are effective during multiple episodes of thrombocytopenia: the EUROSPRITE trial","volume":"8","author":"Cazenave","year":"2001","journal-title":"Transfusion Clinique et Biologique"},{"issue":"Supp 1","key":"10.1002\/14651858.CD010984.pub2-BIB0192|cit192","first-page":"100s","article-title":"Results of the EUROSPRITE phase III trial: INTERCEPT buffy coat platelet concentrates (IPC) provide effective hemostasis for thrombocytopenic (TCP) patients (PTS)","volume":"8","author":"Ljungman","year":"2001","journal-title":"Transfusion Clinique et Biologique"},{"issue":"Supp 1","key":"10.1002\/14651858.CD010984.pub2-BIB0193|cit193","first-page":"100","article-title":"The EUROSPRITE phase III trial of INTERCEPT buffy coat platelet concentrates (IPC) demonstrates IPC are safe when transfused to thrombocytopenic (TCP) patients (PTS)","volume":"8","author":"Pamphilon","year":"2001","journal-title":"Transfusion Clinique et Biologique"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1182\/blood-2002-03-0932","article-title":"Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial","volume":"101","author":"Rhenen","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.transci.2008.05.013","article-title":"Platelet transfusions in clinical practice at a multidisciplinary hospital in North India","volume":"39","author":"Verma","year":"2008","journal-title":"Transfusion and Apheresis Science"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V91.10.3601","article-title":"Safety and cost effectiveness of a 10 x 109\/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 109\/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukaemia","volume":"91","author":"Wandt","year":"1998","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010984.pub2-BIB0197|cit197","first-page":"A140","article-title":"The 10\/NL trigger for prophylactic platelet transfusion in AML: a prospective comparative multicenter study","volume":"70","author":"Wandt","year":"1995","journal-title":"Annals of Hematology"},{"issue":"11","key":"10.1002\/14651858.CD010984.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"Abstract","DOI":"10.1182\/blood.V106.11.428.428","article-title":"Routine prophylactic platelet transfusions are not necessary in patients with acute myeloid leukaemia. A therapeutic transfusion strategy is safe","volume":"106","author":"Wandt","year":"2005","journal-title":"Blood"},{"issue":"Abstract 2782","key":"10.1002\/14651858.CD010984.pub2-BIB0199|cit199","first-page":"706a","article-title":"New strategy for platelet transfusion for patients with acute myeloid leukaemia: routine prophylactic transfusion replaced by therapeutic transfusion","volume":"100","author":"Wandt","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bmt.1705246","article-title":"A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation","volume":"37","author":"Wandt","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"38","key":"10.1002\/14651858.CD010984.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1055\/s-0030-1263332","article-title":"Indication for platelet transfusion in patients with haematological\u00a0disease: less is more. [German]","volume":"135","author":"Wandt","year":"2010","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0202|cit202","unstructured":"NCT00521664 A trial comparing a prophylactic with a therapeutic platelet strategy in two groups http:\/\/clinicaltrials.gov\/show\/NCT00521664"},{"issue":"21","key":"10.1002\/14651858.CD010984.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1182\/blood.V124.21.3686.3686","article-title":"Consolidation therapy is associated with significantly lower bleeding risk compared to induction therapy in patients with acute myeloid leukemia","volume":"124","author":"Schaefer-Eckart","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD010984.pub2-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"(Abstract)","DOI":"10.1182\/blood.V108.11.577.577","article-title":"Interim analysis of a prospective randomised study comparing a therapeutic platelet strategy with the prophylactic platelet transfusion standard in patients after autologous peripheral stem cell transplantation (ASCT). 48th Annual Meeting of the American Society of Hematology","volume":"108","author":"Schaefer-Eckart","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0206|cit205","first-page":"(Abstract)","article-title":"Experience with a therapeutic platelet transfusion strategy in patients with acute myeloid leukemia. Final results of a randomized multicenter study comparing a prophylactic with a therapeutic transfusion strategy","volume":"33","author":"Wandt","year":"2010","journal-title":"Onkologie"},{"issue":"Supplement","key":"10.1002\/14651858.CD010984.pub2-BIB0207|cit206","first-page":"(Abstract)","article-title":"Experience with a therapeutic platelet transfusion strategy in acute myeloid leukaemia: Preliminary results of a randomised multicenter study after enrolment of 175 patients. 51st ASH Meeting and Exposition","volume":"11","author":"Wandt","year":"2009","journal-title":"Blood"},{"issue":"9850","key":"10.1002\/14651858.CD010984.pub2-BIB0208|cit207","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study","volume":"380","author":"Wandt","year":"2012","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0205|cit208","first-page":"S23","article-title":"A therapeutic platelet transfusion strategy without routine prophylactic transfusion is feasible and safe and reduces platelet transfusion numbers significantly: final analysis of a randomised study after high-dose chemotherapy and PBSCT","volume":"43 Supp 1","author":"Wandt","year":"2009","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0209|cit209","first-page":"Abstract 286","article-title":"Therapeutic platelet transfusion strategy without routine prophylactic transfusion is feasible and safe and reduces platelet transfusion numbers significantly: preliminary analysis of a randomized study in patients after high dose chemotherapy and autologous peripheral blood stem cell transplantation","volume":"112","author":"Wandt","year":"2008","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ajh.10119","article-title":"Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial","volume":"70","author":"Wang","year":"2002","journal-title":"American Journal of Hematology"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0211|cit211","first-page":"482","article-title":"Using evidence-based guideline for prophylactic platelet transfusion in patient with myelodysplastic syndrome","volume":"5","author":"Wang","year":"2005","journal-title":"Chinese Journal of Evidence-Based Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00063-009-1070-2","article-title":"Low levels of prothrombin (INR) and platelets do not increase the risk of significant bleeding when placing central venous catheters","volume":"104","author":"Weigand","year":"2009","journal-title":"Medizinische Klinik"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood.V83.10.3028.3028","article-title":"Bedside filtration of blood products in the prevention of HLA alloimmunization: A prospective randomized study. Alloimmunization Study Group","volume":"83","author":"Williamson","year":"1994","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0031-3955(02)00026-3","article-title":"New approaches to hematopoietic cell transplantation for hematological diseases in children","volume":"49","author":"Woodard","year":"2002","journal-title":"Pediatric Clinics of North America"},{"issue":"7","key":"10.1002\/14651858.CD010984.pub2-BIB0215|cit215","first-page":"27","article-title":"Platelet transfusion practice in a tertiary care hospital","volume":"13","author":"Zahur","year":"2002","journal-title":"Medical Forum Monthly"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MOH.0000000000000087","article-title":"Prophylactic platelet transfusions: should they be a treatment of the past?","volume":"21","author":"Zeller","year":"2014","journal-title":"Current Opinion in Hematology"},{"issue":"6","key":"10.1002\/14651858.CD010984.pub2-BIB0217|cit217","first-page":"568","article-title":"Clinical assessment of preventing febrile nonhemolytic transfusion reaction by leucocyte depleted blood transfusion","volume":"10","author":"Zhao","year":"2002","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/bbmt.2002.v8.pm12434952","article-title":"A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000\/\u00b5L versus 20,000\/\u00b5L trigger","volume":"8","author":"Zumberg","year":"2002","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2141.2009.07840.x","article-title":"Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill","volume":"147","author":"Benson","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1172\/JCI110375","article-title":"Hemostatic function, survival, and membrane glycoprotein changes in young versus old rabbit platelets","volume":"68","author":"Blajchman","year":"1981","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12026-009-8106-9","article-title":"The platelet as an immune cell - CD40 ligand and transfusion immune modulation","volume":"45","author":"Blumberg","year":"2009","journal-title":"Immunology Research"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0222|cit222","volume-title":"The 2011 Annual SHOT Report","author":"Bolton-Maggs PHB","year":"2012"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1200\/JCO.2010.31.4310","article-title":"Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial","volume":"29","author":"Burnett","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0224|cit224","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009072","article-title":"Pathogen-reduced platelets for the prevention of bleeding","author":"Butler","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0225|cit225","unstructured":"Cancer Research UK Percentage change in European age-standardised three year average incidence rates, males, UK, 1991-2001 and 2008-2010 http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0226|cit226","unstructured":"Centers for Disease Control (CDC) United States Cancer Statistics National Program of Cancer Registries (NPCR) http:\/\/www.cdc.gov\/cancer\/npcr\/"},{"issue":"7","key":"10.1002\/14651858.CD010984.pub2-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.bjc.6601696","article-title":"Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001","volume":"90","author":"Coleman","year":"2004","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1537-2995.2004.03231.x","article-title":"Methods for the analysis of bleeding outcomes in randomized trials of platelet transfusion triggers","volume":"44","author":"Cook","year":"2004","journal-title":"Transfusion"},{"issue":"7","key":"10.1002\/14651858.CD010984.pub2-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1182\/blood-2007-07-100669","article-title":"Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin","volume":"111","author":"Serna","year":"2008","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0230|cit230","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.1910.04330140029009","article-title":"The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and coagulation time and report of 3 cases of hemorrhagic disease relieved by transfusion","volume":"55","author":"Duke","year":"1910","journal-title":"Journal of the American Medical Association"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.2010.08483.x","article-title":"Platelet transfusions for patients with haematological malignancies: who needs them?","volume":"154","author":"Estcourt","year":"2011","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1423-0410.2012.01627.x","article-title":"Platelet transfusions in haematology patients: are we using them appropriately?","volume":"103","author":"Estcourt","year":"2012","journal-title":"Vox Sanguinis"},{"issue":"7","key":"10.1002\/14651858.CD010984.pub2-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/trf.12058","article-title":"The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions","volume":"53","author":"Estcourt","year":"2013","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0235|cit235","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010984","article-title":"Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation","author":"Estcourt","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0236|cit236","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010982","article-title":"Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation","author":"Estcourt","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0237|cit237","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010983","article-title":"Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation","author":"Estcourt","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0238|cit238","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010981","article-title":"A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation","author":"Estcourt","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0239|cit239","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/trf.12441","article-title":"Does bleeding affect patient reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review","volume":"54","author":"Estcourt","year":"2014","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0241|cit241","unstructured":"McMaster University GRADEpro 2015"},{"issue":"16","key":"10.1002\/14651858.CD010984.pub2-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: a global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V66.5.1105.1105","article-title":"Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement","volume":"66","author":"Hanson","year":"1985","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD010984.pub2-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1537-2995.2008.01731.x","article-title":"Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review","volume":"48","author":"Heddle","year":"2008","journal-title":"Transfusion"},{"issue":"7","key":"10.1002\/14651858.CD010984.pub2-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood-2008-09-178236","article-title":"A randomized controlled trial comparing standard and low dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia","volume":"113","author":"Heddle","year":"2009","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/9781444311761.ch6","article-title":"Investigation of acute transfusion reactions","volume-title":"Practical Transfusion Medicine","author":"Heddle","year":"2009"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1537-2995.1998.38798346631.x","article-title":"Mathematical modelling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient","volume":"38","author":"Hersh","year":"1998","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0248|cit248","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0249|cit249","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0250|cit250","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V46.4.567.567","article-title":"Ultrastructural changes of endothelium associated with thrombocytopenia","volume":"46","author":"Kitchens","year":"1975","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0252|cit252","volume-title":"The 2009 Annual SHOT Report","author":"Knowles","year":"2010"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0253|cit253","volume-title":"The 2010 Annual SHOT Report","author":"Knowles","year":"2011"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1537-2995.2004.03153.x","article-title":"Measurement of bleeding severity: a critical review","volume":"44","author":"Koreth","year":"2004","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0255|cit255","unstructured":"Kumar A Mhaskar R Grossman BJ Kaufman RM Tobian AAR Kleinman S Platelet transfusion: a systematic review of the clinical evidence Transfusion 10.1111\/trf.12943"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0256|cit256","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra0800887","article-title":"Platelets, petechiae and preservation of the vascular wall","volume":"359","author":"Nachman","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0258|cit258","unstructured":"ONS Cancer incidence and mortality tables and charts Office of National Statistics www.ons.gov.uk\/ons\/"},{"issue":"24","key":"10.1002\/14651858.CD010984.pub2-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"7","key":"10.1002\/14651858.CD010984.pub2-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/bmt.2012.66","article-title":"The EBMT activity survey: 1990-2010","volume":"47","author":"Passweg","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3324\/haematol.2009.008649","article-title":"Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission","volume":"94","author":"Patel","year":"2009","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0262|cit262","unstructured":"Pavenski K Rebulla P Duquesnoy R Saw CL Slichter SJ Tanael S et al. International Collaboration for Guideline Development Implementation. Evaluation for Transfusion Therapies Collaborators Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review Transfusion 10.1111\/trf.12175"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-3148.2010.01037.x","article-title":"Screening of platelet for bacterial contamination at the Welsh Blood Service","volume":"21","author":"Pearce","year":"2011","journal-title":"Transfusion Medicine"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0264|cit264","first-page":"17","article-title":"An audit of use and wastage in the north west of England and North Wales: where have all the platelets gone?","volume":"34","author":"Pendry","year":"2011","journal-title":"Blood and Transplant Matters"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1537-2995.1985.25686071434.x","article-title":"Diagnostic and pathogenetic considerations in transfusion-related acute lung injury","volume":"25","author":"Popovsky","year":"1985","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0266|cit266","first-page":"351","article-title":"Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England","volume":"4","author":"Rachet","journal-title":"The Lancet Oncology"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0267|cit267","unstructured":"The Nordic Cochrane Centre Review Manager (RevMan) 2014"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/09537100903388359","article-title":"Effect of beta-blockers, Ca2+antagonists, and benzodiazepines on bleeding incidence in patients with chemotherapy induced thrombocytopenia","volume":"21","author":"Rysler","year":"2010","journal-title":"Platelets"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0269|cit269","doi-asserted-by":"publisher","first-page":"e8933","DOI":"10.1371\/journal.pone.0008933","article-title":"The average body surface area of adult cancer patients in the UK: a multicentre retrospective study","volume":"5","author":"Sacco","year":"2010","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0270|cit270","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD010984.pub2-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1054\/bjoc.2001.1859","article-title":"Body surface area estimation in children using weight alone: application in paediatric oncology","volume":"85","author":"Sharkey","year":"2001","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2002-03-0958","article-title":"Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors","volume":"101","author":"Silliman","year":"2003","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev.me.31.020180.002453","article-title":"Controversies in platelet transfusion therapy","volume":"31","author":"Slichter","year":"1980","journal-title":"Annual Reviews of Medicine"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2141.2005.05769.x","article-title":"Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?","volume":"131","author":"Stanworth","year":"2005","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD010984.pub2-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.tmrv.2009.11.002","article-title":"Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions","volume":"24","author":"Stanworth","year":"2010","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0277|cit277","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions . Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0278|cit278","doi-asserted-by":"crossref","unstructured":"Tierney JF Stewart LA Ghersi D Burdett S Sydes MR Practical methods for incorporating summary time-to-event data into meta-analysis Trials 2007 10.1186\/1745-6215-8-16","DOI":"10.1186\/1745-6215-8-16"},{"issue":"2","key":"10.1002\/14651858.CD010984.pub2-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.transci.2009.07.005","article-title":"Platelet utilization in the developing world: strategies to optimize platelet transfusion practices","volume":"41","author":"Verma","year":"2009","journal-title":"Transfusion and Apheresis Science"},{"key":"10.1002\/14651858.CD010984.pub2-BIB0280|cit280","volume-title":"WHO Handbook for Reporting Results of Cancer Treatment","author":"WHO","year":"1979"},{"issue":"5","key":"10.1002\/14651858.CD010984.pub2-BIB0281|cit281","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004269.pub3","article-title":"Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation","author":"Estcourt","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010984.pub2-BIB0282|cit282","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004269.pub2","article-title":"Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation","author":"Stanworth","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010984.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T02:05:53Z","timestamp":1718157953000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010984.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":282,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010984.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]}}}